◆英語タイトル：Zynerba Pharmaceuticals Inc (ZYNE) - Financial and Strategic SWOT Analysis Review
Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz Inc, is a developer of next-generation synthetic cannabinoid therapeutics. The company provides pipeline product candidates such as ZYN002 and ZYN001. Its ZYN002 is a synthetic CBD, a non-psychoactive cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery. Zynerba Pharmaceuticals’s ZYN001 is a pro-drug of THC which enables the transdermal delivery through skin and into the circulatory system via patch. The company’s pipeline candidates target various indications which include refractory focal epilepsy, fragile x syndrome, developmental and epileptic encephalopathies, fibromyalgia and peripheral neuropathic pain, among others. Zynerba Pharmaceuticals is headquartered in Devon, Pennsylvania, the US.
Zynerba Pharmaceuticals Inc Key Recent Developments
Feb 20,2019: Zynerba Pharmaceuticals appoints Pamela Stephenson to Board of Directors
Nov 08,2018: Zynerba Pharmaceuticals reports third quarter 2018 financial results and operational highlights
Oct 11,2018: Zynerba Pharmaceuticals to Present at the 2018 BIO Investor Forum
Aug 02,2018: Zynerba Pharmaceuticals reports second quarter 2018 financial results and operational highlights
May 08,2018: Zynerba Pharmaceuticals Reports First Quarter 2018 Financial Results and Operational Highlights
This comprehensive SWOT profile of Zynerba Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Zynerba Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Zynerba Pharmaceuticals Inc – Key Information
Zynerba Pharmaceuticals Inc – Overview
Zynerba Pharmaceuticals Inc – Key Employees
Zynerba Pharmaceuticals Inc – Key Employee Biographies
Zynerba Pharmaceuticals Inc – Key Operational Heads
Zynerba Pharmaceuticals Inc – Major Products and Services
Zynerba Pharmaceuticals Inc – History
Zynerba Pharmaceuticals Inc – Company Statement
Zynerba Pharmaceuticals Inc – Locations And Subsidiaries
Zynerba Pharmaceuticals Inc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Zynerba Pharmaceuticals Inc – Business Description
Zynerba Pharmaceuticals Inc – Corporate Strategy
Zynerba Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Zynerba Pharmaceuticals Inc – Strengths
Zynerba Pharmaceuticals Inc – Weaknesses
Zynerba Pharmaceuticals Inc – Opportunities
Zynerba Pharmaceuticals Inc – Threats
Zynerba Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Zynerba Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Zynerba Pharmaceuticals Inc, Key Information
Zynerba Pharmaceuticals Inc, Key Ratios
Zynerba Pharmaceuticals Inc, Share Data
Zynerba Pharmaceuticals Inc, Major Products and Services
Zynerba Pharmaceuticals Inc, History
Zynerba Pharmaceuticals Inc, Key Employees
Zynerba Pharmaceuticals Inc, Key Employee Biographies
Zynerba Pharmaceuticals Inc, Key Operational Heads
Zynerba Pharmaceuticals Inc, Other Locations
Zynerba Pharmaceuticals Inc, Subsidiaries
Zynerba Pharmaceuticals Inc, Key Manufacturing facilities
Zynerba Pharmaceuticals Inc, Key Competitors
Zynerba Pharmaceuticals Inc, SWOT Analysis
Zynerba Pharmaceuticals Inc, Ratios based on current share price
Zynerba Pharmaceuticals Inc, Annual Ratios
Zynerba Pharmaceuticals Inc, Interim Ratios
Capital Market Ratios
List of Figures
Zynerba Pharmaceuticals Inc, Performance Chart
Zynerba Pharmaceuticals Inc, Ratio Charts
| ★海外企業調査レポート[Zynerba Pharmaceuticals Inc (ZYNE)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら